Detalles de la búsqueda
1.
Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.
J Transl Med
; 15(1): 115, 2017 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28549432
2.
High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.
Cancer Gene Ther
; 30(1): 51-61, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031661
3.
CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure.
Front Immunol
; 13: 904497, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35874685
4.
Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.
Clin Transl Immunology
; 10(4): e1268, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33968404
5.
The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma.
Oncoimmunology
; 8(2): e1546543, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30713807
6.
Correction to: High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.
Cancer Gene Ther
; 30(1): 219, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36460806
7.
Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.
PLoS One
; 7(11): e48848, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23144996
Resultados
1 -
7
de 7
1
Próxima >
>>